AU2003204320A1 - Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof - Google Patents

Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof

Info

Publication number
AU2003204320A1
AU2003204320A1 AU2003204320A AU2003204320A AU2003204320A1 AU 2003204320 A1 AU2003204320 A1 AU 2003204320A1 AU 2003204320 A AU2003204320 A AU 2003204320A AU 2003204320 A AU2003204320 A AU 2003204320A AU 2003204320 A1 AU2003204320 A1 AU 2003204320A1
Authority
AU
Australia
Prior art keywords
intermediates
treatment
benign prostatic
prostatic hyperplasia
heterocycles useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003204320A
Other versions
AU2003204320B2 (en
Inventor
Richard H. Hutchings
Haripada Khatuya
Gee-Hong Kuo
Xiaobing Li
William V. Murray
Catherine P. Prouty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1998/021470 external-priority patent/WO1999019299A1/en
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Priority to AU2003204320A priority Critical patent/AU2003204320B2/en
Priority claimed from AU2003204320A external-priority patent/AU2003204320B2/en
Publication of AU2003204320A1 publication Critical patent/AU2003204320A1/en
Application granted granted Critical
Publication of AU2003204320B2 publication Critical patent/AU2003204320B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003204320A 1997-10-09 2003-05-22 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof Ceased AU2003204320B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003204320A AU2003204320B2 (en) 1997-10-09 2003-05-22 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60061618 1997-10-09
PCT/US1998/021470 WO1999019299A1 (en) 1997-10-09 1998-10-09 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
AU10783/99A AU1078399A (en) 1997-10-09 1998-10-09 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
AU2003204320A AU2003204320B2 (en) 1997-10-09 2003-05-22 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU10783/99A Division AU1078399A (en) 1997-10-09 1998-10-09 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof

Publications (2)

Publication Number Publication Date
AU2003204320A1 true AU2003204320A1 (en) 2003-06-19
AU2003204320B2 AU2003204320B2 (en) 2006-01-19

Family

ID=39301727

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003204320A Ceased AU2003204320B2 (en) 1997-10-09 2003-05-22 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof

Country Status (1)

Country Link
AU (1) AU2003204320B2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH078795B2 (en) * 1989-09-06 1995-02-01 日立化成工業株式会社 Urinary disorder treatment
US5605896A (en) * 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
US5332732A (en) * 1992-09-11 1994-07-26 Mcneilab, Inc. Thiophene and pyridine antipsychotic agents

Similar Documents

Publication Publication Date Title
IL130762A0 (en) Quinoline and quinazoline compounds useful in therapy particularly in the treatment of benign prostatic hyperplasia
AU6028598A (en) Non-iron metalloporphyrins and methods of use
AU9300598A (en) Methods of treating and preventing endometriosis with phytoestrogens
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU2235395A (en) Biological markers of benign prostate hyperplasia
AU4479997A (en) Sustained delivery device and methods of making and using the same
AU9016898A (en) Methods and compositions for treatment of restenosis
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
EP0855910A4 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
AU2418499A (en) Org-5222 in the treatment of depression
AP9901684A0 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU3118297A (en) Sok-1 and methods of use
HK1030776A1 (en) Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
AU1295099A (en) Water repellent restorative and process of use
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
AU6570998A (en) Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis
AU2003204320A1 (en) Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
AU2115197A (en) Compositions and methods useful in the detection and/or treatment of cancerous conditions
AU5457694A (en) Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
AU1454199A (en) Pdgf-mediated microvascular communication and methods of use thereof
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof
EP0748627A3 (en) Melatonin agonists for use in the treatment of benign prostatic hyperplasia
EP1140906A4 (en) Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
AU2002300904A1 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia